COVID-19 pandemic
The Food and Drug Administration authorizes the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11, becoming the first vaccine to be approved for children in the United States.
Sources: CNBC
Changes
- The Food and Drug Administration authorizes the Pfizer–BioNTech COVID-19 vaccine for children aged 5 to 11, becoming the first vaccine to be approved for that age group kn the United States.
- The Food and Drug Administration authorizes the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11, becoming the first vaccine to be approved for children in the United States.